Accelerate Diagnostics (STU:1A80) Operating Cash Flow per Share : €-2.33 (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Operating Cash Flow per Share?

Accelerate Diagnostics's operating cash flow per share for the three months ended in Mar. 2024 was €-0.41. Accelerate Diagnostics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.33.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Accelerate Diagnostics's Operating Cash Flow per Share or its related term are showing as below:

STU:1A80' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -145 Med: -15.2 Max: 56.3
Current: 29

During the past 13 years, Accelerate Diagnostics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.30% per year. The lowest was -145.00% per year. And the median was -15.20% per year.

STU:1A80's 3-Year OCF Growth Rate is ranked better than
81.51% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs STU:1A80: 29.00

Accelerate Diagnostics Operating Cash Flow per Share Historical Data

The historical data trend for Accelerate Diagnostics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Operating Cash Flow per Share Chart

Accelerate Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-10.70

-7.40

-6.79

-5.60

-2.95

Accelerate Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-1.27	-0.91	-0.53	-0.49	-0.41

Competitive Comparison of Accelerate Diagnostics's Operating Cash Flow per Share

For the Medical Devices subindustry, Accelerate Diagnostics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's Price-to-Operating-Cash-Flow falls into.

Accelerate Diagnostics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Accelerate Diagnostics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-36.86	/	12.477
	=	-2.95

Accelerate Diagnostics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-7.776	/	19.216
	=	-0.40

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.33

Accelerate Diagnostics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics (STU:1A80) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

AXDX:USA AXDX:Mexico 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

Accelerate Diagnostics (STU:1A80) Headlines

No Headlines